drug discovery and development. Chapter 3 examines three case studies as illustrations of both the promise and the challenges of genomic-based drug discovery and development. Chapter 4 looks at the application of emerging technologies, such as next-generation sequencing, to this field. Chapter 5 examines several specific evolving paradigms in genomic-based drug development, approval, and prescribing. Finally, Chapter 6 features comments and discussions drawn from throughout the workshop on overcoming the challenges and achieving the promise of genomic-based drug discovery and development.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement